Detalhe da pesquisa
1.
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥â¯60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.
Euro Surveill
; 29(3)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38240061
2.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill
; 29(13)2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551095
3.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Euro Surveill
; 29(8)2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390651
4.
Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal.
Emerg Infect Dis
; 29(3): 569-575, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737101
5.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997666
6.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill
; 28(47)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997665
7.
Monitoring COVID-19 and Influenza: The Added Value of a Severe Acute Respiratory Infection Surveillance System in Portugal.
Can J Infect Dis Med Microbiol
; 2023: 6590011, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36846348
8.
COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022.
Euro Surveill
; 27(37)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111555
9.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Euro Surveill
; 27(21)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35620997
10.
No effect modification of influenza virus vaccine effectiveness by age or chronic condition was observed in the 2010/11 to 2017/18 seasons.
Pharmacoepidemiol Drug Saf
; 30(10): 1411-1419, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096151
11.
mRNA vaccine effectiveness against COVID-19-related hospitalisations and deaths in older adults: a cohort study based on data linkage of national health registries in Portugal, February to August 2021.
Euro Surveill
; 26(38)2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558406
12.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Euro Surveill
; 26(29)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296676
13.
Understanding influenza vaccination among Portuguese elderly: the social ecological framework.
Health Promot Int
; 35(6): 1427-1440, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32105311
14.
Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population.
BMC Public Health
; 19(1): 1690, 2019 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842831
15.
Performance of surveillance case definitions for respiratory syncytial virus infections through the sentinel influenza surveillance system, Portugal, 2010 to 2018.
Euro Surveill
; 24(45)2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718741
16.
Impact of influenza vaccination programmes among the elderly population on primary care, Portugal, Spain and the Netherlands: 2015/16 to 2017/18 influenza seasons.
Euro Surveill
; 24(45)2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718740
17.
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.
Euro Surveill
; 22(41)2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29043961
18.
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
Euro Surveill
; 22(30)2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28797322
19.
Absence of prenatal ultrasound surveillance: Data from the Portuguese congenital anomalies registry.
Birth Defects Res A Clin Mol Teratol
; 106(6): 489-93, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27301562
20.
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Euro Surveill
; 21(7): pii=30139, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26924024